HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Enso Wearable Demonstrates Significant Improvements in Both Mobility & Pain Reduction
This study further validates the efficacy of Enso. Enso has already helped thousands by improving functional mobility and quickly delivering noninvasive, nonaddictive, lasting pain relief via an easy-to-use wearable,” said Dr. Jeffrey Krauss, Hinge Health’s chief medical officer.
CyberKnife® Robotic Radiotherapy Platform Recent Data
The Journal of Neurosurgery analysis shows the platform can be used to treat a broad range of neurological conditions at various stages in the treatment journey – from first-line to adjuvant therapy and palliation – reinforcing its use in daily practice.
Participants with Mobility Challenges Demonstrate 143% Improvement to Gait with Neural Sleeve in Cionic’s Latest Feasibility Study
Cionic’s bionic clothing is designed to help restore mobility and improve the manner of walking (gait) for people with cerebral palsy, multiple sclerosis, stroke, and other neurological disorders.
Harvard MedTech’s Vx Therapy Is Effective in Promoting Pain Resiliency
The “Pain and Therapy” article documents results with a cohort of adult patients aged 18 – 65 who were treated from April 2019 to April 2020 for acute or chronic workplace injuries and were on workers compensation.
Spaulding Rehabilitation Hospital at Harvard Medical School and Highland Instruments, Inc., Jointly Announce Release of ALGEA 2 Clinical Trial Results
Spaulding Principal Investigator, Felipe Fregni, MD, PhD, MMSc, MPH, MEd, stated "We have seen great results with ESStim™ across the chronic pain and movement disorder indications.
Medtronic Self-expanding TAVR Platform Shows Excellent Longer-term Performance at 5 Years in SURTAVI Trial
Data showed that the hemodynamic (blood flow) benefits of the Medtronic CoreValve™ and Evolut™ platforms were maintained at five years with an excellent safety profile and stable valve performance in patients with symptomatic, severe aortic stenosis who are at an intermediate risk for open-heart surgery.
New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with Indigo® System CAT™ RX Catheter in High-Risk Patients with Acute Coronary Syndrome
CHEETAH clinical study of its Indigo® System CAT™ RX Catheter successfully met the primary endpoint and demonstrated high rates of blood clot removal, blood flow restoration and myocardial perfusion in conjunction with percutaneous coronary intervention (PCI) in patients with high thrombus burden.
Wegovy™ Demonstrated Significant and Sustained Weight Loss in Two-Year Study in Adults With Obesity
The STEP 5 trial investigated Wegovy™ vs. placebo, both used with a reduced-calorie meal plan and increased physical activity for the treatment of obesity (BMI ≥30 kg/m2) or overweight (BMI ≥27 kg/ m2) in 304 adults with at least one weight-related comorbidity for 104 weeks (two years)
SPYRAL AFFIRM Study Shows Patients with High Blood Pressure Are Interested in an Interventional Procedure RX Option
SPYRAL AFFIRM study, also concluded that blood pressure reduction was the most important driver of patient preference over all other attributes like medication burden and treatment (including interventional treatment-related) risks.